![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Handbook on Injectable Drugs 17+
Skyscape Medpresso Inc
Розроблено для iPad
-
- Безкоштовно
- Пропозиції покупок в програмі
Знімки екрана
Опис
“Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.
For over 50 years American Society of Health-System Pharmacists is the most comprehensive reference on injectable drug data. 2024 edition features 400+ monographs on parenteral drugs, 24,500+ compatibility pairs, 3,700+ unique references
5-Star Rating from Doody's Review Service and Doody's Core Titles List Selection
ASHP® Injectable Drug Information™ 2024 content is interactive, mobile, and updated quarterly. Includes monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information..
Key Features
* Quick data search for 358 drugs
* 417 monographs on parenteral drugs available in the United States and in other countries
* Monographs cross-referenced with American Society of Health-System Pharmacists (AHFS) Drug Information through AHFS classification numbers
* More than 500 revisions to existing monographs (affecting 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and enhancements to the more than 24,100 compatibility pairs contained in ASHP® Injectable Drug Information™ 2024.
* How to prepare, store and administer drugs
* Info accumulated from 3,603 references
* Drugs listed alphabetically by generic name for efficient searching, with brand names listed
WHAT'S NEW
ASHP® Injectable Drug Information™ 2024 includes
* 18 new monographs, bringing the total in this edition to 417 monographs on parenteral drugs available in the United States and in other countries.
* More than 500 revisions to existing monographs (affecting nearly 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and other enhancements to the more than 24,100 compatibility pairs
* The information cited throughout the text has been compiled from 3603 references, including 195 new to this edition. Because information from pharmaceutical manufacturers had not been uniquely cited until the 18th edition, the number of unique references supporting ASHP® Injectable Drug Information™ 2024 information actually greatly exceeds this number.
* While primary, peer-reviewed literature remains a major source of compatibility and stability information, ongoing efforts are underway to provide increased specificity of references to the pharmaceutics research of drug manufacturers. Other relevant information and pertinent study details supplied by corresponding authors of the published literature also have been incorporated when available.
Content licensed from printed edition ISBN 10: 1585286834
Content licensed from printed edition ISBN 13: 9781585286836
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $49.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Editor(s): ASHP
Publisher: American Society of Health-System Pharmacists
Що нового
Версія 5.4.2
* 18 new monographs, bringing the total in this edition to 417 monographs on parenteral drugs available in the United States and in other countries.
* More than 500 revisions to existing monographs (affecting nearly 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and other enhancements to the more than 24,100 compatibility pairs
* The information cited throughout the text has been compiled from 3603 references, including 195 new to this edition. Because information from pharmaceutical manufacturers had not been uniquely cited until the 18th edition, the number of unique references supporting ASHP® Injectable Drug Information™ 2024 information actually greatly exceeds this number.
* While primary, peer-reviewed literature remains a major source of compatibility and stability information, ongoing efforts are underway to provide increased specificity of references to the pharmaceutics research of drug manufacturers. Other relevant information and pertinent study details supplied by corresponding authors of the published literature also have been incorporated when available.
Покупки в програмі
Приватність програми
Розробник (Skyscape Medpresso Inc) зазначив, що до процедур забезпечення приватності програми може входити обробка даних, як це описано нижче. Докладніші відомості наведено на сторінці політики приватності розробника.
Дані, не пов’язані з вами
Перелічені нижче дані можуть збиратися, однак не пов’язуються з вашою особою:
- Користувацький вміст
- Історія пошуку
- Ідентифікатори
- Дані про використання
- Діагностикa
Процедури роботи з конфіденційною інформацією можуть відрізнятися з урахуванням, наприклад, вашого віку або функцій, якими ви користуєтеся. Докладніше
Інформація
- Постачальник
- Skyscape Medpresso Inc
- Розмір
- 36,7 МБ
- Категорія
- Медицина
- Сумісність
-
- iPhone
- Потрібна iOS 12.0 чи новішої версії.
- iPad
- Потрібна iPadOS 12.0 чи новішої версії.
- iPod touch
- Потрібна iOS 12.0 чи новішої версії.
- Mac
- Потрібні macOS 11.0 або новішої версії та Mac із чіпом Apple M1 або новішої версії.
- Apple Vision
- Потрібна visionOS 1.0 чи новішої версії.
- Мови
-
Англійська
- Вікова категорія
- 17+ Рідкі/помірні сцени зі вживанням алкоголю, тютюну чи наркотиків або згадки про них Часті/надмірні сцени медичної/лікувальної тематики
- Copyright
- © (c) 1998-2030 Skyscape Medpresso, Inc. All rights reserved.
- Ціна
- Безкоштовно
- Покупки в програмі
-
- HBK on Injectable Drugs 1Y Sub 3 990,00 RUB
- Handbook on Injectable Drugs 4 490,00 RUB